https://scholars.lib.ntu.edu.tw/handle/123456789/612041
標題: | Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide | 作者: | Liou, Bo-Huang Cheng, Chih-Ning Lin, Ya-Ting Lin, Yu-Jou YU-CHUNG CHUANG KUAN-YIN LIN Liu, Wen-Chun SHU-WEN LIN CHING-HUA KUO HSIN-YUN SUN CHIEN-CHING HUNG |
關鍵字: | drug-drug interaction; integrase strand transfer inhibitor; protein-adjusted 95% effective concentration; rifamycin; trough concentration | 公開日期: | 2021 | 出版社: | JOHN WILEY & SONS LTD | 卷: | 24 | 期: | 11 | 來源出版物: | Journal of the International AIDS Society | 摘要: | Short-course preventive therapy with 1-month course of daily administration of isoniazid (300-mg) plus rifapentine (600-mg) (1HP) and 3-month course of weekly administration of isoniazid (900-mg) plus rifapentine (900-mg) (3HP) has higher completion rates than 9-month course of daily isoniazid (9H) for individuals with latent tuberculosis infection (LTBI). We aimed to evaluate the effect, safety and tolerability of 1HP in people living with HIV (PLWH) and LTBI who received coformulated bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF). |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/612041 | ISSN: | 1758-2652 | DOI: | 10.1002/jia2.25844 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。